DK0951294T3 - Sårhelende formuleringer indeholdende humanplasmafibronectin - Google Patents

Sårhelende formuleringer indeholdende humanplasmafibronectin

Info

Publication number
DK0951294T3
DK0951294T3 DK97951010T DK97951010T DK0951294T3 DK 0951294 T3 DK0951294 T3 DK 0951294T3 DK 97951010 T DK97951010 T DK 97951010T DK 97951010 T DK97951010 T DK 97951010T DK 0951294 T3 DK0951294 T3 DK 0951294T3
Authority
DK
Denmark
Prior art keywords
wound healing
human plasma
formulations containing
containing human
plasma fibronectin
Prior art date
Application number
DK97951010T
Other languages
English (en)
Inventor
Andre Beaulieu
Robert Paquin
Original Assignee
Andre Beaulieu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andre Beaulieu filed Critical Andre Beaulieu
Application granted granted Critical
Publication of DK0951294T3 publication Critical patent/DK0951294T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97951010T 1996-12-17 1997-12-12 Sårhelende formuleringer indeholdende humanplasmafibronectin DK0951294T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/767,868 US5821220A (en) 1995-06-07 1996-12-17 Method of producing concentrated non-buffered solutions of fibronectin
PCT/CA1997/000966 WO1998026797A1 (en) 1996-12-17 1997-12-12 Wound healing formulations containing human plasma fibronectin

Publications (1)

Publication Number Publication Date
DK0951294T3 true DK0951294T3 (da) 2003-11-17

Family

ID=25080820

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97951010T DK0951294T3 (da) 1996-12-17 1997-12-12 Sårhelende formuleringer indeholdende humanplasmafibronectin

Country Status (11)

Country Link
US (1) US5821220A (da)
EP (1) EP0951294B1 (da)
JP (1) JP2001510463A (da)
AT (1) ATE245443T1 (da)
AU (1) AU747209B2 (da)
CA (1) CA2275193A1 (da)
DE (1) DE69723725T2 (da)
DK (1) DK0951294T3 (da)
ES (1) ES2203827T3 (da)
PT (1) PT951294E (da)
WO (1) WO1998026797A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6528483B2 (en) * 1995-06-07 2003-03-04 André Beaulieu Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en) * 1995-06-07 2006-09-26 Andre Beaulieu Solid wound healing formulations containing fibronectin
US20030105007A1 (en) * 1995-06-07 2003-06-05 Andre Beaulieu PDGF-betabeta and fibronectin combined in a solid wound dressing for the treatment of wounds
IL138594A0 (en) * 1998-04-01 2001-10-31 Biotech Australia Pty Ltd Use of protease inhibitors for treating skin wounds
DE10242320A1 (de) * 2002-09-12 2004-03-25 Thomas Steinmetz Golfspielanlage
GB0327046D0 (en) * 2003-11-20 2003-12-24 Queen Mary & Westfield College Regulation of sperm function
CA2841795C (en) 2011-07-05 2020-09-15 The Research Foundation For The State University Of New York Compositions and methods for spinal disc repair and other surgical and non-surgical indications
HK1246177A1 (zh) * 2015-09-04 2018-09-07 赛巴纳医药有限公司 局部用红细胞生成素制剂和用其提高伤口愈合的方法及其美容用途
CN109568652A (zh) * 2018-12-26 2019-04-05 粤肽生物科技(珠海)有限公司 促进伤口快速愈合的敷料组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4341764A (en) * 1980-03-05 1982-07-27 Cutter Laboratories, Inc. Method of preparing fibronectin and antihemophilic factor
JPS61103836A (ja) * 1984-10-24 1986-05-22 Green Cross Corp:The フイブロネクチン製剤
US4837019A (en) * 1986-08-11 1989-06-06 Charles Of The Ritz Group Ltd. Skin treatment composition and method for treating burned skin
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US5641483A (en) * 1995-06-07 1997-06-24 Beaulieu; Andre Wound healing formulations containing human plasma fibronectin

Also Published As

Publication number Publication date
ATE245443T1 (de) 2003-08-15
EP0951294B1 (en) 2003-07-23
JP2001510463A (ja) 2001-07-31
DE69723725D1 (de) 2003-08-28
AU5470998A (en) 1998-07-15
CA2275193A1 (en) 1998-06-25
DE69723725T2 (de) 2004-04-22
US5821220A (en) 1998-10-13
AU747209B2 (en) 2002-05-09
PT951294E (pt) 2003-10-31
WO1998026797A1 (en) 1998-06-25
ES2203827T3 (es) 2004-04-16
EP0951294A1 (en) 1999-10-27

Similar Documents

Publication Publication Date Title
PT784481E (pt) Formulacoes para cicatrizacao de feridas contendo fibronectina do plasma humano
ES2187665T3 (es) Uso de la il-10 para curar heridas con una cicatrizacion reducida.
ATE512650T1 (de) Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
PT859596E (pt) Formulacoes em gel contendo factores de crescimento
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
DK0923378T3 (da) Fremme af sårheling ved kemisk modificerede tetracykliner
AU524756B2 (en) Wound dressing
ES2063250T3 (es) Uso de la trombospondina para facilitar la curacion de las heridas.
PT951294E (pt) Formulaoes cicatrizantes contendo fibronectina plasmetica humana
AU4306197A (en) Use of inhibitors of the activity of retinoic acid to promote healing
DE69820254D1 (de) Dermales hüllgewebe in der wundheilung
DE69716460D1 (de) Wundheilung und behandlung von fibrose
NO981866D0 (no) Terapeutisk anvendelse av hemoglobin for Õ fremme sÕrheling
NO934317D0 (no) Anvendelse av visse metanbisfosfonsyrederivater i brudd-heling
BR0109896A (pt) Composição tópica em gel, curativo de feridas, seu método e uso
IL138709A0 (en) METHODS FOR PROMOTING THE HEALING OF CUTANEOUS WOUNDS AND ULCERS USING COMPOSITIONS OF α-D-GLUCANS
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
WO1998030212A3 (de) Verwendung von aminothiazolen zur verbesserung der wundheilung
GB2368523A (en) Solid wound healing formulations containing fibronectin
IT1125491B (it) Preparato per il trattamento di ferite,piaghe,ulcerazioni ed altre affezioni cutanee essudative
ITPD920102A1 (it) Composizione farmaceutica utile per trattare malattie gastroenteriche, ferite e ustioni e come agente emostatico
DK0784481T3 (da) Sårhelingsformuleringer indeholdende humant plasmafibronektin
UA42335A (uk) Спосіб лікування гнійних ран